A new implantable hearing system, the direct acoustic cochlear stimulator (DACS) is presented. This system is based on the principle of a power-driven stapes prosthesis and intended for the treatment of severe mixed hearing loss due to advanced otosclerosis. It consists of an implantable electromagnetic transducer, which transfers acoustic energy directly to the inner ear, and an audio processor worn externally behind the implanted ear. The device is implanted using a specially developed retromeatal microsurgical approach. After removal of the stapes, a conventional stapes prosthesis is attached to the transducer and placed in the oval window to allow direct acoustical coupling to the perilymph of the inner ear. In order to restore the natural sound transmission of the ossicular chain, a second stapes prosthesis is placed in parallel to the first one into the oval window and attached to the patient’s own incus, as in a conventional stapedectomy. Four patients were implanted with an investigational DACS device. The hearing threshold of the implanted ears before implantation ranged from 78 to 101 dB (air conduction, pure tone average, 0.5–4 kHz) with air-bone gaps of 33–44 dB in the same frequency range. Postoperatively, substantial improvements in sound field thresholds, speech intelligibility as well as in the subjective assessment of everyday situations were found in all patients. Two years after the implantations, monosyllabic word recognition scores in quiet at 75 dB improved by 45–100 percent points when using the DACS. Furthermore, hearing thresholds were already improved by the second stapes prosthesis alone by 14–28 dB (pure tone average 0.5–4 kHz, DACS switched off). No device-related serious medical complications occurred and all patients have continued to use their device on a daily basis for over 2 years.

1.
Ball GR, et al: Implantable and external hearing systems having a floating mass transducer. US patent, 1999.
2.
Bernhard H, Fontannaz J, Peclat C, Haller M, Cauwels K, Kloeck B, Huybrechts K, Stieger C, Häusler R, Kaiser T: Implantable actuator for hearing aid applications. International Patent WO 2006/058368, 2006a.
3.
Bernhard H, Stieger C, Perriard Y: New implantable hearing device based on a micro-actuator that is directly coupled to the inner ear fluid, EMBC06. IEEE Eng Med Biol Soc Proc, 2006b.
4.
Carhart R: Audiometric manifestations of pre-clinical stapes fixation. Trans Am Otol Soc 1964;52:132–148.
5.
Chen DA, Backous DD, Arriaga MA, Garvin R, Kobylek D, Littman T, Walgren S, Lura D: Phase 1 clinical trial results of the Envoy System: a totally implantable middle ear device for sensorineural hearing loss. Otolaryngol Head Neck Surg 2004;131:904–916.
6.
Colletti V, Soli SD, Carner M, Colletti L: Treatment of mixed hearing losses via implantation of a vibratory transducer on the round window. Int J Audiol 2006;45:600–608.
7.
Cox RM, Alexander GC: The abbreviated profile of hearing aid benefit. Ear Hear 1995;16:176–186.
8.
Dutt SN, Ray J, Hadjihannas E, Cooper H, Donaldson I, Proops DW: Medical and surgical complications of the second 100 adult cochlear implant patients in Birmingham. J Laryngol Otol 2005;119:759–764.
9.
Green KM, Bhatt YM, Saeed SR, Ramsden RT: Complications following adult cochlear implantation: experience in Manchester. J Laryngol Otol 2004;118:417–420.
10.
Häusler R: Fortschritte in der Stapeschirurgie. Laryngorhinootologie 2000;79(suppl 2):95–139.
11.
Häusler R: Cochlear implantation without mastoidectomy: the pericanal electrode insertion technique. Acta Otolaryngol 2002;122:715–719.
12.
Heiland KE, Goode RL, Asai M, Huber AM: A human temporal bone study of stapes footplate movement. Am J Otol 1999;20:81–86.
13.
Huttenbrink KB: Current status and critical reflections on implantable hearing aids. Am J Otol 1999;20:409–415.
14.
Jenkins HA, Atkins JS, Horlbeck D, et al: U.S. phase I preliminary results of use of the otologics MET fully-implantable ossicular stimulator. Otolaryngol Head Neck Surg 2007;137:206–212.
15.
Jorge JR, Pfister M, Zenner HP, Zalaman IM, Maassen MM: In vitro model for intraoperative adjustments in an implantable hearing aid (MET). Laryngoscope 2006;116:473–481.
16.
Kasic JF, Fredrickson JM: The otologics MET ossicular stimulator. Otolaryngol Clin North Am 2001;34:501–513.
17.
Ko WH, Zhu WL, Kane M, Maniglia AJ: Engineering principles applied to implantable otologic devices. Otolaryngol Clin North Am 2001;34:299–314.
18.
Kompis M: Sprachaudiometrie; in Kompis M (ed): Audiologie. Bern, Hans Huber, 2004a.
19.
Kompis M: Überhören und Vertäuben; in Kompis M (ed): Audiologie. Bern, Hans Huber, 2004b.
20.
Kompis M, Krebs M, Häusler R: Speech understanding in quiet and in noise with bone-anchored hearing aids BAHA compact and BAHA Divino. Acta Otolaryngol 2007;127:829–835.
21.
Needham AJ, Jiang D, Bibas A, Jeronimidis G, O’Connor AF: The effects of mass loading the ossicles with a floating mass transducer on middle ear transfer function. Otol Neurotol 2005;26:218–224.
22.
Parkin JL, Parkin MJ: Multichannel cochlear implantation with percutaneous pedestal. Ear Nose Throat J 1994;73:156–158, 163–164.
23.
Shea JJ Jr: Forty years of stapes surgery. Am J Otol 1998;19:52–55.
24.
Stieger C, Bernhard H, Waeckerlin D, Kompis M, Burger J, Häusler R: Human temporal bones versus a mechanical model to evaluate three middle-ear transducers. J Rehabil Res Dev, in press.
25.
Todt I, Seidl RO, Ernst A: Hearing benefit of patients after Vibrant Soundbridge implantation. ORL J Otorhinolaryngol Relat Spec 2005;67:203–206.
26.
Tschopp K, Zust H: Performance of normally hearing and hearing-impaired listeners using a German version of the SPIN test. Scand Audiol 1994;23:241–247.
27.
Voss SE, Rosowski JJ, Merchant SN, Peake WT: Acoustic responses of the human middle ear. Hear Res 2000;150:43–69.
28.
Zenner HP, Leysieffer H: Active electronic cochlear implants for middle and inner ear hearing loss – a new era in ear surgery. I. Basic principles and recommendations on nomenclature (in German). HNO 1997;45:749–757.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.